Metabolic effects of low-dose dopamine infusion in normal volunteers
- PMID: 2176947
- DOI: 10.1042/cs0790605
Metabolic effects of low-dose dopamine infusion in normal volunteers
Abstract
1. Dopamine in 5% (w/v) D-glucose was infused into five healthy male volunteers at doses of 2, 5 and 10 micrograms min-1 kg-1 over three sequential periods of 45 min each. 2. Oxygen consumption, respiratory exchange ratio, blood glucose concentration and plasma levels of free fatty acids, glycerol, lactate, dopamine, adrenaline and noradrenaline were measured. The results were compared with values obtained during infusion over the same time period of the corresponding volumes of 5% (w/v) D-glucose alone. 3. Energy expenditure calculated from the oxygen consumption and the respiratory exchange ratio was higher than control values during infusion of dopamine (P less than 0.001, analysis of variance) specifically at a rate of 10 micrograms min-1 kg-1 (P less than 0.05) when it was 14% higher, but not at a rate 2 of or 5 micrograms min-1 kg-1. The plasma noradrenaline concentration was 74 and 230% and the blood glucose concentration was 21 and 36% higher than control values at 5 and 10 micrograms of dopamine min-1 kg-1, respectively (P less than 0.01). At 10 micrograms of dopamine min-1 kg-1 the plasma free fatty acid concentration was 70% and the plasma glycerol concentration was 80% higher than during the control infusion (P less than 0.01). The respiratory exchange ratio and the plasma lactate concentration were the same in the two groups and did not alter during the dopamine infusion. The plasma adrenaline concentration rose significantly (P less than 0.01), but only transiently, during dopamine infusion at a rate of 2 micrograms min-1 kg-1. 4. Dopamine at low doses has metabolic effects. It increases the blood glucose concentration and the circulating noradrenaline level at an infusion rate of 5 micrograms min-1 kg-1. It increases energy expenditure and circulating free fatty acid and glycerol levels at an infusion rate of 10 micrograms min-1 kg-1, presumably due to stimulation of lipolysis.
Similar articles
-
Are the effects of noradrenaline, adrenaline and dopamine infusions on VO2 and metabolism transient?Intensive Care Med. 1995 Jan;21(1):50-6. doi: 10.1007/BF02425154. Intensive Care Med. 1995. PMID: 7560474 Clinical Trial.
-
Metabolic effects of dobutamine in normal man.Clin Sci (Lond). 1992 Jan;82(1):77-83. doi: 10.1042/cs0820077. Clin Sci (Lond). 1992. PMID: 1310921 Clinical Trial.
-
Metabolic changes during dopamine infusion in dogs.Br J Anaesth. 1979 Nov;51(11):1021-5. doi: 10.1093/bja/51.11.1021. Br J Anaesth. 1979. PMID: 518802
-
The metabolic effects of dopamine in man.Eur J Clin Pharmacol. 1984;26(1):23-8. doi: 10.1007/BF00546703. Eur J Clin Pharmacol. 1984. PMID: 6143668
-
Cardiovascular and metabolic response to adrenaline infusion in weight-losing patients with and without cancer.Clin Physiol. 1989 Oct;9(5):427-39. doi: 10.1111/j.1475-097x.1989.tb00997.x. Clin Physiol. 1989. PMID: 2582730
Cited by
-
Are the effects of noradrenaline, adrenaline and dopamine infusions on VO2 and metabolism transient?Intensive Care Med. 1995 Jan;21(1):50-6. doi: 10.1007/BF02425154. Intensive Care Med. 1995. PMID: 7560474 Clinical Trial.
-
Endomyocardial biopsy in a patient with hemorrhagic pheochromocytoma presenting as inverted Takotsubo cardiomyopathy.Heart Vessels. 2013 Mar;28(2):255-63. doi: 10.1007/s00380-012-0247-4. Epub 2012 Apr 5. Heart Vessels. 2013. PMID: 22476628
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous